TY - JOUR
T1 - Decline of hepatitis A antibodies during the first 7 months of life in full-term and preterm infants
AU - Linder, N.
AU - Karetnyi, Y.
AU - Gidony, Y.
AU - Dagan, R.
AU - Ohel, G.
AU - Le, E.
AU - Mendelson, E.
AU - Barzilai, A.
PY - 1999
Y1 - 1999
N2 - In a previous study we have shown that transplacental transfer of hepatitis A antibodies to preterm infants does not differ from that observed in full-term infants. This follow-up study was designed to investigate the decline of hepatitis A virus (HAV) antibodies during the first 7 months of life in full-term and preterm infants, in an endemic region for hepatitis A. Two hundred and fifty newborn infants - 147 full-term and 103 preterm infants - were enrolled. Blood samples from the infants were taken at birth, and at 3 and 7 months of age. Anti-HAV titers were determined by ELISA. A concentration of ≥ 1:20 mlU/ml was considered protective. Protective hepatitis A antibodies were present at birth in 48.3% of all full-term and 49.5% of all premature infants. By the age of 7 months only 13% of full-term and 21.7% of preterm infants still had protective titers. For the seropositive full-term infants the geometric mean titers (GMT) were 15,698, 6107 and 345 at birth, 3 months and 7 months, respectively, and for preterm infants, 10,378, 2307 and 225 at birth, 3 months and 7 months, respectively. Significant differences in GMT between preterm and full-term infants were found at birth and at 3 months of age (P < 0.05). In a region endemic for hepatitis A, low levels of anti-HAV at 7 months of age may justify trials on infant vaccination since this is the most effective way to eliminate hepatitis A from circulation.
AB - In a previous study we have shown that transplacental transfer of hepatitis A antibodies to preterm infants does not differ from that observed in full-term infants. This follow-up study was designed to investigate the decline of hepatitis A virus (HAV) antibodies during the first 7 months of life in full-term and preterm infants, in an endemic region for hepatitis A. Two hundred and fifty newborn infants - 147 full-term and 103 preterm infants - were enrolled. Blood samples from the infants were taken at birth, and at 3 and 7 months of age. Anti-HAV titers were determined by ELISA. A concentration of ≥ 1:20 mlU/ml was considered protective. Protective hepatitis A antibodies were present at birth in 48.3% of all full-term and 49.5% of all premature infants. By the age of 7 months only 13% of full-term and 21.7% of preterm infants still had protective titers. For the seropositive full-term infants the geometric mean titers (GMT) were 15,698, 6107 and 345 at birth, 3 months and 7 months, respectively, and for preterm infants, 10,378, 2307 and 225 at birth, 3 months and 7 months, respectively. Significant differences in GMT between preterm and full-term infants were found at birth and at 3 months of age (P < 0.05). In a region endemic for hepatitis A, low levels of anti-HAV at 7 months of age may justify trials on infant vaccination since this is the most effective way to eliminate hepatitis A from circulation.
UR - http://www.scopus.com/inward/record.url?scp=0033000403&partnerID=8YFLogxK
U2 - 10.1007/BF02560513
DO - 10.1007/BF02560513
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0033000403
SN - 0300-8126
VL - 27
SP - 128
EP - 131
JO - Infection
JF - Infection
IS - 2
ER -